Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $114.00

U.S. Physical Therapy, Inc. (NYSE:USPH) has been assigned a consensus rating of “Buy” from the five brokerages that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $114.00.

A number of analysts recently weighed in on USPH shares. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 price target for the company. JPMorgan Chase & Co. boosted their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Finally, Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $100.00 to $115.00 in a research report on Monday, December 16th.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the sale, the chief operating officer now owns 7,106 shares of the company’s stock, valued at $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nancy Ham sold 1,172 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now owns 1,112 shares in the company, valued at $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 7,412 shares of company stock worth $706,605. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors and hedge funds have recently bought and sold shares of USPH. State Street Corp increased its position in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after buying an additional 99,244 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of U.S. Physical Therapy by 763.7% during the second quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after acquiring an additional 61,474 shares during the last quarter. Southernsun Asset Management LLC increased its position in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after purchasing an additional 52,062 shares in the last quarter. Penn Davis Mcfarland Inc. acquired a new position in U.S. Physical Therapy in the 3rd quarter valued at about $2,552,000. Finally, Rockefeller Capital Management L.P. lifted its holdings in U.S. Physical Therapy by 18.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock valued at $13,578,000 after purchasing an additional 25,393 shares in the last quarter.

U.S. Physical Therapy Price Performance

USPH stock opened at $90.26 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.36 billion, a P/E ratio of 96.02, a PEG ratio of 4.23 and a beta of 1.46. The business has a 50 day simple moving average of $91.12 and a 200-day simple moving average of $89.56. U.S. Physical Therapy has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.95%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.